Rating Card

premium

Unlock Expert's Rating and Top Picks Portfolio

Curated by Michael O'Reilly since 2020
1550+ opinions with 4.81 rating (one of the best performing expert)

Latest Top Picks

Stock Opinions by Samuel D. Isaly

TOP PICK
Growing very well. Their biggest drug is for high blood pressure but also have a good product line for cancer treatment. Not many patent exposures in the near-term.
biotechnology / pharmaceutical

Unlock the latest expert's opinion. Its free

Create a FREE account to see the latest opinions & get alerts about when to buy, sell or hold stocks

Unlock the latest opinion & get signals
TOP PICK
Lots of new products. Rapid profit growth.
biotechnology / pharmaceutical
TOP PICK
A very rapidly growing company. Earnings per share growth is in excess of 20% yearly. PE ratio barely more than that.
biotechnology / pharmaceutical
TOP PICK
Has a low market cap. Have a drug that extends life in lung cancer which should be approved around the turn of the year.
biotechnology / pharmaceutical
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »